Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: The genetics of inherited retinal diseases in understudied ethnic groups: Novel associations, challenges, and perspectives. | Front Genet | 2022 | 36081992 | PubTator, text mining | PubMed |
| Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine Development. | J Oncol | 2022 | 36072981 | PubTator, text mining | PubMed |
| Current and Future Treatment of Retinitis Pigmentosa. | Clin Ophthalmol | 2022 | 36071725 | PubTator, text mining | PubMed |
| Two cases of unilateral cone-rod dysfunction presenting in adult females. | Doc Ophthalmol | 2022 | 36070159 | PubTator, text mining | PubMed |
| Mutation spectrum of non-syndromic hearing loss in the UAE, a retrospective cohort study and literature review. | Mol Genet Genomic Med | 2022 | 36056583 | PubTator, text mining | PubMed |
| Case report: Disease phenotype associated with simultaneous biallelic mutations in ABCA4 and USH2A due to uniparental disomy of chromosome 1. | Front Genet | 2022 | 36051698 | PubTator, text mining | PubMed |
| Pan-cancer analysis suggests histocompatibility minor 13 is an unfavorable prognostic biomarker promoting cell proliferation, migration, and invasion in hepatocellular carcinoma. | Front Pharmacol | 2022 | 36046831 | PubTator, text mining | PubMed |
| Pathogenesis and Treatment of Usher Syndrome Type IIA. | Asia Pac J Ophthalmol (Phila) | 2022 | 36041150 | PubTator, text mining | PubMed |
| Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients. | Evid Based Complement Alternat Med | 2022 | 36034941 | PubTator, text mining | PubMed |
| Global spectrum of USH2A mutation in inherited retinal dystrophies: Prompt message for development of base editing therapy. | Front Aging Neurosci | 2022 | 36034145 | PubTator, text mining | PubMed |
| Pseudorabies Virus: From Pathogenesis to Prevention Strategies. | Viruses | 2022 | 36016260 | PubTator, text mining | PubMed |
| Viruses Hijack ERAD to Regulate Their Replication and Propagation. | Int J Mol Sci | 2022 | 36012666 | PubTator, text mining | PubMed |
| Inherited Retinal Dystrophy in Southeastern United States: Characterization of South Carolina Patients and Comparative Literature Review. | Genes (Basel) | 2022 | 36011402 | PubTator, text mining | PubMed |
| Phenotypic and Genetic Characteristics in a Cohort of Patients with Usher Genes. | Genes (Basel) | 2022 | 36011334 | PubTator, text mining | PubMed |
| Baseline Microperimetry and OCT in the RUSH2A Study: Structure-Function Association and Correlation With Disease Severity. | Am J Ophthalmol | 2022 | 36007554 | PubTator, text mining | PubMed |
| A Genotype-Phenotype Analysis of Usher Syndrome in Puerto Rico: A Case Series. | Cureus | 2022 | 36003347 | PubTator, text mining | PubMed |
| Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer. | JCI Insight | 2022 | 35993362 | PubTator, text mining | PubMed |
| Identification of the alpha linolenic acid metabolism-related signature associated with prognosis and the immune microenvironment in nasopharyngeal carcinoma. | Front Endocrinol (Lausanne) | 2022 | 35992141 | PubTator, text mining | PubMed |
| Molecular diagnose of a large hearing loss population from China by targeted genome sequencing. | J Hum Genet | 2022 | 35982127 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Genomic and Expression Data Identified Potential Markers for Predicting Prognosis and Immune Response in CRC. | Genet Res (Camb) | 2022 | 35975176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=31